Skip to main content
Log in

One-year outcomes of CCTA alone versus machine learning–based FFRCT for coronary artery disease: a single-center, prospective study

  • Cardiac
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To explore downstream management and outcomes of machine learning (ML)–based CT derived fractional flow reserve (FFRCT) strategy compared with an anatomical coronary computed tomography angiography (CCTA) alone assessment in participants with intermediate coronary artery stenosis.

Methods

In this prospective study conducted from April 2018 to March 2019, participants were assigned to either the CCTA or FFRCT group. The primary endpoint was the rate of invasive coronary angiography (ICA) that demonstrated non-obstructive disease at 90 days. Secondary endpoints included coronary revascularization and major adverse cardiovascular events (MACE) at 1-year follow-up.

Results

In total, 567 participants were allocated to the CCTA group and 566 to the FFRCT group. At 90 days, the rate of ICA without obstructive disease was higher in the CCTA group (33.3%, 39/117) than that (19.8%, 19/96) in the FFRCT group (risk difference [RD] = 13.5%, 95% confidence interval [CI]: 8.4%, 18.6%; p = 0.03). The ICA referral rate was higher in the CCTA group (27.5%, 156/567) than in the FFRCT group (20.3%, 115/566) (RD = 7.2%, 95% CI: 2.3%, 12.1%; p = 0.003). The revascularization-to-ICA ratio was lower in the CCTA group than that in the FFRCT group (RD = 19.8%, 95% CI: 14.1%, 25.5%, p = 0.002). MACE was more common in the CCTA group than that in the FFRCT group at 1 year (HR: 1.73; 95% CI: 1.01, 2.95; p = 0.04).

Conclusion

In patients with intermediate stenosis, the FFRCT strategy appears to be associated with a lower rate of referral for ICA, ICA without obstructive disease, and 1-year MACE when compared to the anatomical CCTA alone strategy.

Key Points

• In stable patients with intermediate stenosis, ML-based FFR CT strategy was associated with a lower referral ICA rate, a lower normalcy rate of ICA, and higher revascularization-to-ICA ratio than the CCTA strategy.

• Compared with the CCTA strategy, ML-based FFR CT shows superior outcome prediction value which appears to be associated with a lower rate of 1-year MACE.

• ML-based FFR CT strategy as a non-invasive “one-stop-shop” modality may be the potential to change diagnostic workflows in patients with suspected coronary artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

CABG:

Coronary artery bypass grafting

CAD:

Coronary artery disease

CCTA:

Coronary computed tomography angiography

FFR:

Fractional flow reserve

FFRCT :

CT derived fractional flow reserve

HR:

Hazard ratio

ICA:

Invasive coronary angiography

LAD:

Left anterior descending artery

LCX:

Left circumflex

MACE:

Major adverse cardiovascular events

ML:

Machine learning

OMT:

Optimal medical therapy

PCI:

Percutaneous coronary intervention

RCA:

Right coronary artery

RD:

Risk difference

References

  1. Shaw LJ, Hausleiter J, Achenbach S et al (2012) Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes:an International Multicenter) registry. J Am Coll Cardio 60:2103–2114

    Article  Google Scholar 

  2. Williams MC, Hunter A, Shah ASV et al (2016) Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol. 67:1759–1768

    Article  Google Scholar 

  3. Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477

    Article  Google Scholar 

  4. Douglas PS, Hoffmann U, Patel MR et al (2015) Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372:1291–1300

    Article  CAS  Google Scholar 

  5. SCOT-HEART Investigators (2015) CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 385:2383–2391

  6. Budoff MJ, Nakazato R, Mancini GB et al (2016)  CT angiography for the prediction of hemodynamic significance in intermediate and severe lesions: head-to-head comparison with quantitative coronary angiography using fractional flow reserve as the reference standard. JACC Cardiovasc Imaging 9:559–564

  7. Jensen JM, Botker HE, Mathiassen ON et al (2018) Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography. Eur Heart J Cardiovasc Imaging 19:405–414

    Article  Google Scholar 

  8. Schwartz FR, Koweek LM, Nørgaard BL (2019) Current evidence in cardiothoracic imaging: computed tomography-derived fractional flow reserve in stable chest pain. J Thorac Imaging 34:12–17

    Article  Google Scholar 

  9. Tesche C, Gray HN (2020) Machine learning and deep neural networks applications in coronary flow assessment: the case of computed tomography fractional flow reserve. J Thorac Imaging 35:S66–S71

    Article  Google Scholar 

  10. Fairbairn TA, Nieman K, Akasaka T et al (2020) Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry. Eur Heart J 39:3701–3711

    Article  Google Scholar 

  11. Patel MR, Norgaard BL, Fairbairn TA et al (2020) 1-year impact on medical practice and clinical outcomes of FFRCT: The ADVANCE registry. JACC Cardiovasc Imaging 13:97–105

    Article  Google Scholar 

  12. Qiao HY, Tang CX, Schoepf UJ et al (2020) Impact of machine learning-based coronary computed tomography angiography fractional flow reserve on treatment decisions and clinical outcomes in patients with suspected coronary artery disease. Eur Radiol 30:5841–5851

    Article  Google Scholar 

  13. Tesche C, Vliegenthart R, Duguay TM et al (2020) Coronary computed tomographic angiography-derived fractional flow reserve for therapeutic decision making. Am J Cardiol 120:2121–2127

    Article  Google Scholar 

  14. Chinnaiyan KM, Akasaka T, Amano T et al (2020) Rationale, design and goals of the HeartFlow Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care (ADVANCE) registry. J Cardiovasc Comput Tomog 11:62–67

    Article  Google Scholar 

  15. Norgaard BL, Hjort J, Gaur S et al (2020) Clinical use of coronary CTA-derived FFR for decision-making in stable CAD. JACC Cardiovasc Imaging 10:541–550

    Article  Google Scholar 

  16. Abbara S, Blanke P, Maroules CD et al (2016) SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 10:435–449

  17. Cury RC, Abbara S, Achenbach S et al (2020) CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10:269–281

    Article  Google Scholar 

  18. Nørgaard BL, Fairbairn TA, Safian RD et al (2019) Coronary CT angiography-derived fractional flow reserve testing in patients with stable coronary artery disease: recommendations on interpretation and reporting. Radiol Cardiothorac Imaging 1:e190050

    Article  Google Scholar 

  19. Hicks KA, Tcheng JE, Biykem B et al (2015) 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials. J Nucl Cardiol 66:403–469

    Article  Google Scholar 

  20. Williams MC, Moss A, Nicol E, Newby DE (2017) Cardiac CT improves outcomes in stable coronary heart disease: results of recent clinical trials. Curr Cardiovasc Imaging Rep 10:14

    Article  Google Scholar 

  21. Jørgensen ME, Andersson C, Nørgaard BL et al (2017) Functional testing or coronary computed tomography angiography in patients with stable coronary artery disease. J Am Coll Cardiol 69:1761–1770

    Article  Google Scholar 

  22. Lu MT, Ferencik M, Roberts R et al (2017) Noninvasive FFR derived from coronary CT angiography: management and outcomes in the PROMISE Trial. JACC Cardiovasc Imaging 10:1350–1358

    Article  Google Scholar 

  23. Ihdayhid AR, Norgaard BL, Gaur S et al (2019) Prognostic value and risk continuum of noninvasive fractional flow reserve derived from coronary CT angiography. Radiology 292:343–351

    Article  Google Scholar 

  24. Chinnaiyan KM, Safian RD, Gallagher ML et al (2019) Clinical use of CT-derived fractional flow reserve in the emergency department. JACC Cardiovasc Imaging 13:452–461

    Article  Google Scholar 

  25. Norgaard BL, Terkelsen CJ, Mathiassen ON et al (2018) Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease. J Am Coll Cardiol 72:2123–2134

    Article  Google Scholar 

  26. Patel MR, Peterson ED, Dai D et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895

  27. Douglas PS, Gianluca P, Hlatky MA et al (2015) Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study. Eur Heart J 36:3359–3367

    Article  CAS  Google Scholar 

  28. Finck T, Hardenberg J, Will A et al (2019) Ten-year follow-up after coronary computed tomography angiography in patients with suspected coronary artery disease. JACC Cardiovasc Imaging 12:1330–1338

    Article  Google Scholar 

  29. Nielsen LH, Botker HE, Sorensen HT et al (2017) Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study. Eur Heart J 38:413–421

    CAS  PubMed  Google Scholar 

  30. Dewey M, Rief M, Martus P et al (2016) Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial. BMJ 355:i5441

  31. Chang HJ, Lin FY, Gebow D et al (2018) Selective referral using CCTA versus direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial. JACC Cardiovasc Imaging 12:1303–1312

    Article  Google Scholar 

  32. De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001

    Article  Google Scholar 

  33. De Bruyne B, Fearon WF, Pijls NH et al (2015) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371:1208–1217

    Article  Google Scholar 

  34. Ciccarelli G, Barbato E, Toth GG et al (2015) Angiography versus hemodynamics to predict the natural history of coronary stenoses: Fractional flow reserve versus in multivessel evaluation 2 substudy. Circulation 137:1475–1485

    Article  Google Scholar 

  35. Coenen A, Kim YH, Kruk M et al (2018) Diagnostic accuracy of a machine-learning approach to coronary computed tomographic angiography-based fractional flow reserve: result from the MACHINE consortium. Circ Cardiovasc Imaging 11:e007217

    Article  Google Scholar 

  36. Tang CX, Wang YN, Zhou F et al (2019) Diagnostic performance of fractional flow reserve derived from coronary CT angiography for detection of lesion-specific ischemia: A multi-center study and meta-analysis. Eur J Radiol 116:90–97

    Article  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the financial support of the National Key Research and Development Program of China (2017YFC0113400 for L.J.Z.).

Funding

This study was supported by the National Key Research and Development Program of China (2017YFC0113400 for L.J.Z.).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Guang Ming Lu or Long Jiang Zhang.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Long Jiang Zhang.

Disclosures

U. Joseph Schoepf is a consultant for and/or receives research support from Astellas, Bayer, Bracco, Elucid BioImaging, General Electric, Guerbet, HeartFlow, and Siemens Healthineers. The other authors have no conflicts of interest to disclose.

Statistics and biometry

Meng Jie Lu kindly provided statistical advice for this manuscript. One of the authors has significant statistical expertise. No complex statistical methods were necessary for this paper.

Informed consent

All participants provided written informed consent.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Prospective

• Observational

• Performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 136 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiao, H.Y., Tang, C.X., Schoepf, U.J. et al. One-year outcomes of CCTA alone versus machine learning–based FFRCT for coronary artery disease: a single-center, prospective study. Eur Radiol 32, 5179–5188 (2022). https://doi.org/10.1007/s00330-022-08604-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-022-08604-x

Keywords

Navigation